| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_027602fa87aa8d1be26e09feb61c4348 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 |
| filingDate |
2015-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e55e830f0a70745665828496e36f3bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_219057be2e08d2d435b94c6e4e3a9dff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63567d778ab06c5c8b359ab2b1d663b7 |
| publicationDate |
2015-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015167368-A1 |
| titleOfInvention |
4, 6-di (3,12-diaza-6, 9-diazoniadispiro [5.2.5.2] hexandecan-1-yl) -2-methyl-5-nitropyrimidine tetrachloride dihydrochloride hexahydrate for the treatment of herpetic infection and a topical pharmaceutical composition |
| abstract |
The invention relates to the use of 4, 6-di(3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecan-1-yl)-2-methyl-5-nitropyrimidine tetrachloride dihydrochloride hexahydrate exhibiting activity against herpes virus, for the prevention and treatment of herpetic infections in humans and animals by topical administration. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017069661-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114644636-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114644636-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106083761-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022124944-A1 |
| priorityDate |
2014-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |